NLP in Healthcare and Life Sciences Market Size Grows at 34.74% CAGR to Soar USD 132.34 Billion 2034

The NLP in healthcare and life sciences market size is calculated at USD 8.97 billion in 2025 and is expected to reach around USD 132.34 billion by 2034, growing at a CAGR of 34.74% for the forecasted period.

Ottawa, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The global NLP in healthcare and life sciences market size was valued at USD 6.66 billion in 2024 and is predicted to hit around USD 132.34 billion by 2034, rising at a 34.74% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.

The global NLP in healthcare and life sciences market is driven by its expanding healthcare applications, growing innovations, and increasing R&D activities.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5559

Key Takeaways

North America held a major revenue share of the market in 2024.
Asia-Pacific is expected to witness the fastest growth in the NLP in healthcare and life sciences market during the forecast period.
By technique, the smart assistance segment dominated the market in 2024.
By technique, the classification & categorization segment is expected to witness the fastest growth in the market during the forecast period.
By end-use, the life science companies segment dominated the market in 2024.
By end-use, the providers segment is expected to witness the fastest growth in the market during the forecast period.

What is NLP in Healthcare and Life Sciences?

The NLP in healthcare and life sciences market is fueled by the need to derive insights from vast quantities of unstructured text data. The NLP in healthcare life science refers to the use of AI applications to process, understand, and interpret vast amounts of data from research papers, clinical notes, and patient feedback in order to streamline administrative tasks, enhance patient care, and accelerate drug discovery. It is being used for various applications such as clinical documentation, patient care, coding, patient monitoring, drug discovery and development, pharmacovigilance, clinical trials management, etc.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What are the Major Growth Drivers in the Market?

The growth in unstructured data is the major driver in the NLP in healthcare and life sciences market, which is increasing the demand for NLP tools. They are being used for managing the research data, clinical notes, medical records, and patient feedback. Moreover, they enhance decision-making and efficiency by converting this data into a structured format. Additionally, growing electronic health record adoption, demand for predictive analytics, digital health initiatives, and advancement in AI technologies are other market drivers.

What are the Key Drifts in the Market?

The NLP in healthcare and life sciences market has been expanding due to the growing funding and collaborations to launch and enhance the use of various NLP solutions.

In August 2025, a total of $21 million in a Series A funding round was secured by the GenAI-native autonomous medical coding platform for healthcare providers, which is Arintra, where the funding will be used to enhance its growth, product development, open a new Bay Area headquarters to meet rising demand, and scale its team.
In August 2025, a strategic investment in an artificial intelligence company focusing on real-time autonomous medical coding, which is Maverick AI, was announced by Infinx. Deep learning AI will be utilized in the coding workflows to enhance compliance, capture revenue faster, and minimize manual efforts in this partnership.
In April 2025, to support accurate and efficient medical coding practices, a collaboration between the Cleveland Clinic and AKASA was announced. Moreover, multiple AI-powered tools of AKASA will be used by the Cleveland Clinic in this collaboration.
In January 2025, a total of $27 million in Series B funding was raised by KODE Health, where this capital will be used in the development of AI-driven tools to minimize workflow fluctuations and manage coding operations more effectively, and to expand its network of certified coding professionals.

What is the Significant Challenge in the Market?

Data privacy and security concerns are the major challenges in NLP in the healthcare and life sciences market. The growing risk of data breaches and cyberattacks decreases their adoption rates and is expected to comply with the HIPAA and GDPR regulations. Moreover, high implementation cost, integration complexities, lack of skilled personnel, domain-specific language, and regulatory barriers are other market limitations.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Regional Analysis

Why did North America Dominate the Market in 2024?

In 2024, North America captured the biggest revenue share in the NLP in healthcare and life sciences market, due to the presence of a well-developed healthcare infrastructure, which increased the adoption of NLP platforms. At the same time, different types of techniques and models were also developed by the advanced industries, where new collaborations accelerated their development. Moreover, the growth in the demand for personalized treatment has also increased the use of NLP solutions for enhancing patient care. Additionally, the growth in R&D investments and increased adoption of advanced technologies supported these innovations, which in turn contributed to the market growth.

What Made the Asia Pacific Show the Fastest Growth in the Market in 2024?

Asia Pacific is expected to host the fastest growth in the NLP in healthcare and life sciences market during the forecast period, driven by growing digitalization and expanding healthcare, which is increasing the utilization of NLP solutions. The growing life science sector is also increasing its use for research and development purposes as well as for clinical trials, which in turn is helping to deal with the growing disease burden and is enhancing the clinical workflows. At the same time, different types of affordable digital platforms are also being launched to support various healthcare services, where government initiative are encouraging their advancements. Thus, this is promoting the market growth.

Download the single region market report @ https://www.towardshealthcare.com/checkout/5559

Segmental Insights

By Technique Analysis

Which Technique Type Segment Held the Dominating Share of the Market in 2024?

By technique, the smart assistance segment held the dominating share of the NLP in the healthcare and life sciences market in 2024, as it helped in enhancing the clinical workflows. At the same time, it also helped in enhancing the medical literature, patient interactions, and provided insights from patient records. Moreover, its 24/7 availability helped in minimizing the administrative burdens.

By technique, the classification & categorization segment is expected to show the highest growth in the market during the predicted time. It is being used for the identification of various diseases, drug discovery, as well as for the sorting of the results and medical records. This, in turn, is increasing their use for various R&D activities.

By End-use Analysis

How the Life Science Companies Segment Dominated the Market in 2024?

By end-use, the life science companies segment held the largest share of the NLP in healthcare and life sciences market in 2024, due to the presence of large volumes of research data. Different types of NLP techniques were used for drug development, target identification, disease diagnosis, and management of the data. Additionally, it was also used in clinical trials for patient recruitment and manufacturing.

By end-use, the providers segment is expected to show the fastest growth rate in the market during the upcoming years. Different types of NLP platforms are being used to enhance patient care by providing personalized treatments and insights. Furthermore, it is also being used to enhance coding, billing, clinical documentation, and to reduce the administrative burdens.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Recent Developments in the Market

In March 2025, to enhance the medical coding automation platform with the use of advanced artificial intelligence (AI) that emulates human reasoning, a collaboration between the University of Texas and CorroHealth Inc. was announced.
In February 2025, a fit-for-purpose Generative AI (GenAI) platform, Cortex, was launched by Indegene, which enhances the medical writing and can be configured with any Large Language Model (LLM).
In May 2025, a new medical coding model was launched by Ambience Healthcare, which identifies ICD-10 codes, which are internationally standardized classifications for different diseases and conditions, listens to patient encounters, and shows 27% relative improvement over physician benchmarks.

Browse More Insights of Towards Healthcare:

The global life science consulting market was valued at USD 34.82 billion in 2024, rising to USD 38.08 billion in 2025, and is projected to reach approximately USD 84.83 billion by 2034, expanding at a CAGR of 9.38% from 2025 to 2034.

The global life science consumables market was valued at USD 29.88 billion in 2024, increasing to USD 31.51 billion in 2025, and is estimated to reach around USD 50.71 billion by 2034, growing at a CAGR of 5.44% during the forecast period.

The global life science equipment market stood at USD 63.72 billion in 2024, increased to USD 67.76 billion in 2025, and is anticipated to reach nearly USD 120.82 billion by 2034, registering a CAGR of 6.34% from 2025 to 2034.

The global life science microscopes market was valued at USD 3.55 billion in 2024, grew to USD 3.71 billion in 2025, and is forecast to reach approximately USD 5.53 billion by 2034, advancing at a CAGR of 4.55% over the forecast period.

The global artificial intelligence (AI) in life sciences market was valued at USD 2.25 billion in 2024, projected to reach USD 2.71 billion in 2025, and expected to achieve USD 14.20 billion by 2034, growing at a CAGR of 20.21% from 2024 to 2034.

The global life science tools market is expected to expand from USD 156.52 billion in 2025 to USD 470.20 billion by 2034, at a strong CAGR of 13% during the forecast period.

The global life science analytics market was valued at USD 10.47 billion in 2024, rose to USD 11.27 billion in 2025, and is projected to reach about USD 21.85 billion by 2034, growing at a CAGR of 7.63% between 2025 and 2034.

The global generative AI in life sciences market was valued at USD 250 million in 2024, increased to USD 302.05 million in 2025, and is anticipated to reach nearly USD 1,657.02 million by 2034, expanding at a CAGR of 20.82% over the forecast period.

The global life science reagents market stood at USD 62.37 billion in 2024, rose to USD 65.91 billion in 2025, and is projected to reach USD 108.74 billion by 2034, registering a CAGR of 5.74% from 2025 to 2034.

The global life sciences BPO (Business Process Outsourcing) market was valued at USD 258 billion in 2024, increased to USD 293.2 billion in 2025, and is forecast to reach approximately USD 895.54 billion by 2034, expanding at a CAGR of 13.64% between 2025 and 2034.

NLP in Healthcare and Life Sciences Market Key Players List

Cerner Enviza
Amazon Web Services
Dassault Systèmes
Authenticx
Intelligent Medical Objects
Google
ITRex Group
IBM
IQVIA
WhizAI
John Snow Labs
Microsoft Corporation
Melax Technologies, Inc.
Veradigm

Download the Competitive Landscape market report @ https://www.towardshealthcare.com/checkout/5559

Segments Covered in The Report

By Technique

Smart Assistance
Optical Character Recognition
Auto Coding
Text Analytics
Speech Analytics
Classification & Categorization

By End-Use

Providers
Payers
Life Science Companies
Others

By Region

North America

U.S.
Canada
Mexico
Rest of North America

South America

Brazil
Argentina
Rest of South America

Europe

Western Europe
- Germany
- Italy
- France
- Netherlands
- Spain
- Portugal
- Belgium
- Ireland
- UK
- Iceland
- Switzerland
- Poland
- Rest of Western Europe
Eastern Europe
- Austria
- Russia & Belarus
- Türkiye
- Albania
- Rest of Eastern Europe

Asia Pacific

China
Taiwan
India
Japan
Australia and New Zealand,
ASEAN Countries (Singapore, Malaysia)
South Korea
Rest of APAC

MEA

GCC Countries
Saudi Arabia
United Arab Emirates (UAE)
Qatar
Kuwait
Oman
Bahrain
South Africa
Egypt
Rest of MEA

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/checkout/5559

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.